Author: Angileri, Salvatore Alessio; Petrillo, Mario; Meglio, Letizia Di; Arrichiello, Antonio; Rodà , Giovanni Maria; Ierardi, Anna Maria; Uberoi, Raman; Carrafiello, Gianpaolo
Title: Adverse Events in Coronavirus Disease Patients Management: A Pictorial Essay Cord-id: 86vhqnok Document date: 2020_7_21
ID: 86vhqnok
Snippet: Clinical manifestation of coronavirus disease (COVID-19) varies from asymptomatic to severe clinical forms that can result in acute respiratory distress syndrome or in multiple organ dysfunction syndromes. There are no guidelines, based on randomized controlled trials, for the treatment of COVID-19 patients. The treatment is based on antiviral drugs, invasive and non-invasive ventilation supports, and anticoagulant therapy. This is a pictorial essay covering the multiple adverse events encounter
Document: Clinical manifestation of coronavirus disease (COVID-19) varies from asymptomatic to severe clinical forms that can result in acute respiratory distress syndrome or in multiple organ dysfunction syndromes. There are no guidelines, based on randomized controlled trials, for the treatment of COVID-19 patients. The treatment is based on antiviral drugs, invasive and non-invasive ventilation supports, and anticoagulant therapy. This is a pictorial essay covering the multiple adverse events encountered during the treatment of COVID-19 patients in an area with a high pandemic incidence. Adverse events are defined as unexpected events following treatment for the infection. The cases described would be useful in aiding early diagnosis, limiting and improving the management of serious complications for patients, and allowing rapid and appropriate treatment.
Search related documents:
Co phrase search for related documents- abdominal wall hernia and magnetic resonance imaging: 1
- acute ards respiratory distress syndrome and administration route: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and lmwh low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and long term morbidity: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute ards respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute ards respiratory distress syndrome and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67
- acute ards respiratory distress syndrome and lung window: 1, 2
- acute ards respiratory distress syndrome and magnetic resonance: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and magnetic resonance imaging: 1, 2, 3, 4, 5, 6
- acute cerebrovascular disease and magnetic resonance: 1, 2, 3
- acute cerebrovascular disease and magnetic resonance imaging: 1, 2, 3
- acute ischemic stroke and administration route: 1
- acute ischemic stroke and lmwh low molecular weight heparin: 1, 2
- acute ischemic stroke and long term morbidity: 1
- acute ischemic stroke and low molecular: 1, 2, 3, 4, 5
- acute ischemic stroke and low molecular weight: 1, 2, 3, 4, 5
- acute ischemic stroke and low molecular weight heparin: 1, 2
Co phrase search for related documents, hyperlinks ordered by date